Clinical trial
Double-Blind Trial of Methylene Blue for Cognitive Dysfunction in Bipolar Disorder
NCT00214877 is registered in ClinicalTrials.gov with Nova Scotia Health Authority as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Double-Blind Trial of Methylene Blue for Cognitive Dysfunction in Bipolar Disorder
- Lead sponsor
- Nova Scotia Health Authority
- Phase
- Phase 3
- Overall status
- Completed
- Start date
- November 30, 2003
- Completion date
- October 31, 2007
- Enrollment
- 40 (estimated)
- Sites
- 2
Conditions
As the registry lists them; a condition with its own page is linked.